BIOMAT Database Logo BIOMAT Database Logo

Hematopoietic stem cell transplantation after posttransplant lymphoproliferative disorder. 2010

Min Joo Kim, and Inho Kim, and Hyun-Mi Bae, and Kyungsuk Seo, and Namjun Park, and Sung-Soo Yoon, and Seonyang Park, and Byoung Kook Kim
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

A 16-yr-old girl received liver transplantation for fulminant hepatitis. Aplastic anemia developed, and she received hematopoietic stem cell transplantation (HSCT). Eleven months after liver transplantation, abdominal lymph node enlargement and colon ulcers were observed, and colon biopsy showed posttransplant lymphoproliferative disorder (PTLD). Immunosuppression reduction was attempted, but it produced no therapeutic effect. Fourteen months after liver transplantation, she received a second HSCT due to engraftment failure, and PTLD resolved completely. The second HSCT can serve as cellular therapy for PTLD.

UI MeSH Term Description Entries
D008232 Lymphoproliferative Disorders Disorders characterized by proliferation of lymphoid tissue, general or unspecified. Duncan's Syndrome,X-Linked Lymphoproliferative Syndrome,Duncan Disease,Epstein-Barr Virus Infection, Familial Fatal,Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males,Familial Fatal Epstein-Barr Infection,Immunodeficiency 5,Immunodeficiency, X-Linked Progressive Combined Variable,Lymphoproliferative Disease, X-Linked,Lymphoproliferative Syndrome, X-Linked, 1,Purtilo Syndrome,X-Linked Lymphoproliferative Disease,X-Linked Lymphoproliferative Disorder,Disease, Duncan,Disease, X-Linked Lymphoproliferative,Diseases, X-Linked Lymphoproliferative,Disorder, Lymphoproliferative,Disorder, X-Linked Lymphoproliferative,Disorders, Lymphoproliferative,Disorders, X-Linked Lymphoproliferative,Epstein Barr Virus Induced Lymphoproliferative Disease In Males,Epstein Barr Virus Infection, Familial Fatal,Familial Fatal Epstein Barr Infection,Immunodeficiency 5s,Immunodeficiency, X Linked Progressive Combined Variable,Lymphoproliferative Disease, X Linked,Lymphoproliferative Diseases, X-Linked,Lymphoproliferative Disorder,Lymphoproliferative Disorder, X-Linked,Lymphoproliferative Disorders, X-Linked,Lymphoproliferative Syndrome, X-Linked,Lymphoproliferative Syndromes, X-Linked,Purtilo Syndromes,Syndrome, Purtilo,Syndrome, X-Linked Lymphoproliferative,Syndromes, Purtilo,Syndromes, X-Linked Lymphoproliferative,X Linked Lymphoproliferative Disease,X Linked Lymphoproliferative Disorder,X Linked Lymphoproliferative Syndrome,X-Linked Lymphoproliferative Diseases,X-Linked Lymphoproliferative Disorders,X-Linked Lymphoproliferative Syndromes
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D016031 Liver Transplantation The transference of a part of or an entire liver from one human or animal to another. Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D018380 Hematopoietic Stem Cell Transplantation Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms. Stem Cell Transplantation, Hematopoietic,Transplantation, Hematopoietic Stem Cell

Related Publications

Min Joo Kim, and Inho Kim, and Hyun-Mi Bae, and Kyungsuk Seo, and Namjun Park, and Sung-Soo Yoon, and Seonyang Park, and Byoung Kook Kim
Posttransplant Lymphoproliferative Disorder in Solid Organ and Hematopoietic Stem Cell Transplantation.
December 2017, Clinics in chest medicine,
Min Joo Kim, and Inho Kim, and Hyun-Mi Bae, and Kyungsuk Seo, and Namjun Park, and Sung-Soo Yoon, and Seonyang Park, and Byoung Kook Kim
Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation.
June 2004, The American journal of surgical pathology,
Min Joo Kim, and Inho Kim, and Hyun-Mi Bae, and Kyungsuk Seo, and Namjun Park, and Sung-Soo Yoon, and Seonyang Park, and Byoung Kook Kim
Posttransplant lymphoproliferative disorder complicating hematopoietic stem cell transplantation in a patient with dyskeratosis congenita.
October 2013, International journal of surgical pathology,
Min Joo Kim, and Inho Kim, and Hyun-Mi Bae, and Kyungsuk Seo, and Namjun Park, and Sung-Soo Yoon, and Seonyang Park, and Byoung Kook Kim
Non-posttransplant lymphoproliferative disorder malignancy after hematopoietic stem cell transplantation in patients with primary immunodeficiency: UK experience.
June 2018, The Journal of allergy and clinical immunology,
Min Joo Kim, and Inho Kim, and Hyun-Mi Bae, and Kyungsuk Seo, and Namjun Park, and Sung-Soo Yoon, and Seonyang Park, and Byoung Kook Kim
Epstein-Barr virus-associated posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation.
November 2014, Current opinion in oncology,
Min Joo Kim, and Inho Kim, and Hyun-Mi Bae, and Kyungsuk Seo, and Namjun Park, and Sung-Soo Yoon, and Seonyang Park, and Byoung Kook Kim
Zanubrutinib Treatment of Central Nervous System Posttransplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report.
January 2021, Frontiers in oncology,
Min Joo Kim, and Inho Kim, and Hyun-Mi Bae, and Kyungsuk Seo, and Namjun Park, and Sung-Soo Yoon, and Seonyang Park, and Byoung Kook Kim
Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation.
April 2021, Annals of hematology,
Min Joo Kim, and Inho Kim, and Hyun-Mi Bae, and Kyungsuk Seo, and Namjun Park, and Sung-Soo Yoon, and Seonyang Park, and Byoung Kook Kim
Interleukin-10 and posttransplant lymphoproliferative disorder after kidney transplantation.
March 1999, Transplantation,
Min Joo Kim, and Inho Kim, and Hyun-Mi Bae, and Kyungsuk Seo, and Namjun Park, and Sung-Soo Yoon, and Seonyang Park, and Byoung Kook Kim
Thymic hyperplasia after lung transplantation imitating posttransplant lymphoproliferative disorder.
January 2011, Case reports in transplantation,
Min Joo Kim, and Inho Kim, and Hyun-Mi Bae, and Kyungsuk Seo, and Namjun Park, and Sung-Soo Yoon, and Seonyang Park, and Byoung Kook Kim
Localized intraocular posttransplant lymphoproliferative disorder after pediatric liver transplantation.
February 2006, Transplantation,
Copied contents to your clipboard!